| Pharmaceutical active ingredients: |
| Abacavir SulfateLamivudineZidovudine |
| Available forms, composition and doses of Viro-ALZ: |
| Tablets; Oral; Abacavir Sulfate 150 mg; Lamivudine 300 mg; Zidovudine 300 mg |
| Viro-ALZ medical category: |
| Human:Nucleoside and nucleotide reverse transcriptase inhibitors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J05AR04 - Zidovudine, Lamivudine and Abacavir |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Ranbaxy |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Lamivudine; Zidovudine; Abacavir | Abacavir Sulfate; Lamivudine; Zidovudine | Aurobindo |
| Tricivir | Abacavir Sulfate; Lamivudine; Zidovudine | GlaxoSmithKline |
| Tricivir GDS12 | Abacavir Sulfate; Lamivudine; Zidovudine | GlaxoSmithKline |
| Triviro-ALZ | Abacavir Sulfate; Lamivudine; Zidovudine | Ranbaxy |
| Trizivir | Abacavir Sulfate; Lamivudine; Zidovudine | GlaxoSmithKline; Shire; ViiV Healthcare; Zuellig Pharma |
| Trivudin | Abacavir; Lamivudine; Zidovudine | Richmond Laboratorios |
| Affirm | Abamectin | Unidentified Pharmaceutical Company |
| Agrimek | Abamectin | Unidentified Pharmaceutical Company |
| Agri-Mek | Abamectin | Unidentified Pharmaceutical Company |
| Avid | Abamectin | Unidentified Pharmaceutical Company |